Treatment with VEGF 165 positive control ± vatalanib showed a similar trend although the effects did not reach statistical significance except for the effect on the area of the rings formed.
← all excerpts
The 5-lipoxygenase/cyclooxygenase-2 cross-over metabolite, hemiketal E<sub>2</sub>, enhances VEGFR2 activation and promotes angiogenesis.
1
—
—